Benzinga | Aug 3, 2021 06:06PM EDT

Aquestive Therapeutics Q2 EPS $(0.33) Beats $(0.44) Estimate, Sales $15.30M Beat $9.48M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.44) by 25 percent. This is a 371.43 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $15.30 million which beat the analyst consensus estimate of $9.48 million by 61.39 percent. This is a 29.41 percent decrease over sales of $21.68 million the same period last year.